Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Verisk Analytics, Inc. Enters into $1.5 Billion Accelerated Share Repurchase Transaction
-
U.S. FDA Grants Reunion Neuroscience’s Luvesilocin (RE104) Breakthrough Therapy Designation Status
-
BridgeBio to Participate in March Investor Conferences
-
Novo Nordisk A/S - share repurchase programme
-
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
-
New, Patent-Pending Tubing Anchor Catcher Now Available from TechTAC
-
Reliance Global Group Closes Enquantum Transaction, Launching Path to Majority Control of Post-Quantum Cybersecurity Platform
-
Notice of Extraordinary General Meeting, proposed company dissolution and delisting
-
NOTICE OF CORRECTION TO NOTICE DATED 18 FEBRUARY 2026 IN RESPECT OF TIME OF MEETING RELATING TO A PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES
-
Rail Vision Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Preliminary financial results for 2025 and guidance for 2026
-
C4 Therapeutics to Participate in Upcoming March Conferences
-
Cyber Acoustics Celebrates 30 Years of Audio Innovation
-
uniQure to Announce 2025 Financial Results
-
Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue
-
Pet Valu Paw-tners with Tim Hortons ® on Roll Up To Win™
-
Koryx Copper Announces Further Significant Drill Results at the Haib Copper Project, Southern Namibia
-
La Mancha Investments S. à r. l. to File Early Warning Report
-
Parex Resources Announces Proposal to Acquire Frontera Energy’s Colombian E&P Assets
-
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
-
Harfang Provides Update at Sky Lake
-
Westhaven Gold and Dundee Corporation Announce Closing of Strategic $85M Earn-In Agreement to Advance Shovelnose and the Spences Bridge Gold Belt, British Columbia
-
Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and Host Investor Webcast to Discuss Presentations
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Loblaw to invest $2.4 billion in the Canadian economy in 2026, with plans to build 70 new stores and create well over 9,000 jobs
-
Tessera Therapeutics Receives U.S. FDA Fast Track and Orphan Drug Designations for its Lead In Vivo Gene Editing Program TSRA-196 for the Treatment of Adults with AATD
-
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
-
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
-
TDG Discovers New ‘4300 Zone’ VMS Lens Below Former Hidden Creek Mine at Anyox Project
-
Abcourt Completes High-Resolution Drone Magnetic Survey on its Flordin Property
-
Electra Approves Construction Budget and Sets Schedule for Completion of its North American Cobalt Sulfate Refinery
-
Itron Announces $600.0 Million Convertible Senior Notes
-
Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
C4 Therapeutics Announces First Patient Dosed in Phase 2 MOMENTUM Trial of Cemsidomide, an Oral IKZF1/3 Degrader, in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
-
Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
PyroGenesis Confirms First Titanium Powder Order with Scientific Aerospace Research Organization
-
Plug To Announce 2025 Fourth Quarter and Year-End Results
-
Syndax Announces Participation in March Investor Conferences
-
Arvinas to Participate in Upcoming Investor Conferences
-
Winnebago Industries to Participate in Fireside Chat at the Raymond James 2026 Institutional Investors Conference
-
Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
-
Pairwise Licenses Fulcrum® CRISPR Platform to Wild Bioscience
-
illumin Holdings Inc. announces date for Fourth Quarter and Year-End 2025 Financial and Operating Results
-
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
-
Signify share repurchase periodic update
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Volatus Aerospace Appoints CTO to Accelerate Sovereign Autonomy and Defence Capabilities
-
Freshpet, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

